AstraZeneca is not entitled to more exclusivity with its antischizophrenic medication, an appeals court agreed last week. The company had claimed its drug, Seroquel, deserved another three-year extension...
Seroquel maker to pay $5.5M in latest settlement related to off-label use of the antipsychotic drug
By
McKnight's Staff
Feb 13, 2013
Drugmaker AstraZeneca recently settled a lawsuit with the state of Kentucky over allegations of improperly marketing its atypical antipsychotic drug Seroquel. Under the settlement, the London-based pharmaceutical...
AstraZeneca pays $68.5 million in Seroquel marketing case
Mar 14, 2011
Pharmaceutical giant AstraZeneca on Thursday agreed to pay $68.5 million to settle allegations that it inappropriately marketed the drug Seroquel for off-label uses, multiple states’ authorities...